In response to
previous TOC, DEA explains that it does use intera ctive form, but
would need electronic signature capability to ful ly convert to an
electronic environment.
Inventory as of this Action
Requested
Previously Approved
03/31/2006
03/31/2006
03/31/2003
818
0
807
818
0
807
0
0
0
Title 21, U.S. Code Sec. 826 and CFR
1303.12(b), requires that U.S. companies who desire to use any
basic class of controlled substances listed in Schedule I or II for
purposes of manufacturing during the next calendar year shall apply
on DEA Form 250 for a procurement quota for such class
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.